The news broke Sunday night that Uber has offered the job of CEO to Dara Khosrowshahi, the outspoken steady hand guiding Bellevue, WA-based online travel giant Expedia (NASDAQ: [[ticker:EXPE]]) for the last dozen years. Khosrowshahi and Uber have not officially confirmed the news as of Monday evening. An internal e-mail from Barry Diller, Expedia chairman, … Continue reading “Who is Dara Khosrowshahi, Uber’s Pick to be CEO?”
Category: Seattle
To Be More Than Quick Splash, Gilead’s CAR-T Purchase Faces Hurdles
[Updated 8/28/17, 6:45p.m. ET. See below.] Gilead Sciences CEO John Milligan promised today that the company’s $11.9 billion acquisition of Kite Pharma and its cutting-edge CAR-T cell therapy would not be a “one and done” proposition. “This is a long-term play with multiple product opportunities,” Milligan said, calling it the foundation of Gilead’s “fairly nascent” … Continue reading “To Be More Than Quick Splash, Gilead’s CAR-T Purchase Faces Hurdles”
Uber Picks Expedia Leader As CEO Over Immelt, Whitman: Reports
In a last-minute shuffle Sunday night, Uber’s strife-ridden board chose Expedia CEO Dara Khosrowshahi as the new chief executive for the troubled ride-hailing giant, Recode reported. Khosrowshahi, whose name hadn’t been rumored as a CEO prospect for Uber, was waiting in the wings after the exits over the weekend of two other finalists for the … Continue reading “Uber Picks Expedia Leader As CEO Over Immelt, Whitman: Reports”
Power to the Patient: Meet Xconomy’s Patient Partnership Award Finalists
It’s clear at this point that patients are no longer just subjects in clinical trials. Thanks to the growing power of patient advocacy groups—and an FDA eager to hear their perspective—patients and drug developers are increasingly finding creating ways to work together, as we’ve seen with the four finalists in the Patient Partnership category of … Continue reading “Power to the Patient: Meet Xconomy’s Patient Partnership Award Finalists”
Gilead Makes Long-Awaited Splash With $12B Bet on Kite, Cell Therapy
Investors have been waiting for years for Gilead Sciences to make another big splash. This morning, it finally did, agreeing to buy Kite Pharma for close to $12 billion in a significant bet on the success of an emerging, cutting edge type of cancer immunotherapy known as CAR-T. Gilead (NASDAQ: [[ticker:GILD]]), of Foster City, CA, … Continue reading “Gilead Makes Long-Awaited Splash With $12B Bet on Kite, Cell Therapy”
Seattle Week in Review: Amazon, Whole Foods, Salmon Spill, Beef Beef
The dog days of summer are here, but there’s plenty of tech news to catch up on. Here’s a look at what’s happening with Amazon’s acquisition of Whole Foods and its amazing impact on real estate in Seattle and elsewhere; a farmed salmon spill in Puget Sound; a careful look at Crowd Cow and the … Continue reading “Seattle Week in Review: Amazon, Whole Foods, Salmon Spill, Beef Beef”
Bio Roundup: Drug Price Debates, NY Bio Blooms & CEOs Take Social Stand
In these politically divided times, Americans this week found near universal agreement on one thing: A celestial event that plunges a summer day into temporary darkness is a captivating experience. The totality of the solar eclipse lasted less than 3 minutes. If you missed it, you’ll have to wait until 2024 for the next one. … Continue reading “Bio Roundup: Drug Price Debates, NY Bio Blooms & CEOs Take Social Stand”
Healthcare + A.I. Northwest Features Microsoft, Allen Institute on Nov. 9
Artificial intelligence technologies could have a profound impact on the healthcare system, and the Northwest’s technology giants, world-class medical and technology researchers, and startup entrepreneurs are poised to make it happen. Xconomy Seattle invites you to preview the opportunities and challenges ahead at Healthcare + A.I. Northwest, our next innovation conference coming up on Nov. … Continue reading “Healthcare + A.I. Northwest Features Microsoft, Allen Institute on Nov. 9”
Stand Up to “Bully” Trump: Bio CEOs Levin, Holtzman Call to Their Peers
Biotech CEOs Jeremy Levin and Steve Holtzman have watched the violence in Charlottesville, VA, and its continuing aftermath with disgust. But they aren’t just upset about the rally, the violence and death, and President Trump’s equivocating blame of “many sides.” Levin, of Ovid Therapeutics (NASDAQ: [[ticker:OVID]]), and Holtzman, of Decibel Therapeutics, have been disappointed with … Continue reading “Stand Up to “Bully” Trump: Bio CEOs Levin, Holtzman Call to Their Peers”
Xconomy Presents: Healthcare + A.I. Northwest
If healthcare is to be transformed by artificial intelligence, Seattle could be the place to make it happen. With a legacy of IT innovation in computing, telecom, web services, and more, coupled with unique strengths in life sciences and medical devices, the area is poised to leverage advances in computer vision, natural language processing, and … Continue reading “Xconomy Presents: Healthcare + A.I. Northwest”
Memphis Meats Cooks Up $17M Funding Round for Lab-Grown “Meat”
Memphis Meats says it has developed a way to grow animal cells into products that have the look, texture, and taste of meat from farm-grown chickens. The San Francisco Bay area startup is now working to scale up its production process, and it has raised $17 million in funding toward that goal. The Series A … Continue reading “Memphis Meats Cooks Up $17M Funding Round for Lab-Grown “Meat””
The Downside of Immersive Tech: An Increasingly Isolated World
As an entrepreneur who has been involved in tech and media for over two decades, I have seen my share of disruptions (I so hate that word!) and even participated in a few. Back in the 1990s, while we were developing some broadband technologies at Sourcecom, my first startup, we also had to develop the … Continue reading “The Downside of Immersive Tech: An Increasingly Isolated World”
Scott Miller Talks Dragon Innovation’s Winding Journey to Avnet Deal
It’s funny how relationships can come full circle in the business world. The seeds of Dragon Innovation’s sale to Avnet, announced Tuesday, were planted over a decade ago in China, says Dragon co-founder and CEO Scott Miller. At the time, he was running iRobot’s operations there alongside his future Dragon co-founder Herman Pang, he says. … Continue reading “Scott Miller Talks Dragon Innovation’s Winding Journey to Avnet Deal”
With $45M in New Cash, Skytap Covers Terrain Missed by Cloud Giants
Despite their size, the cloud computing services provided by tech giants such as Microsoft, Amazon, and Google, don’t work for everyone. Skytap, a Seattle-based company that spun out of University of Washington at the dawn of cloud computing to help businesses move traditional IT functions to the cloud, on Tuesday announced it has raised $45 … Continue reading “With $45M in New Cash, Skytap Covers Terrain Missed by Cloud Giants”
Microsoft Can Recognize Speech as Well as Humans on Switchboard Task
Microsoft researchers have been steadily improving the accuracy of their speech recognition technology—a necessary precursor to many other artificial intelligence applications—achieving parity with human performance on a benchmark task called Switchboard last year. Since then, the bar for human parity has been moved. Another research group improved the human word error rate to 5.1 percent … Continue reading “Microsoft Can Recognize Speech as Well as Humans on Switchboard Task”
On Drug Pricing: FDA Backs Up Its Calls for Increased Competition
FDA Commissioner Scott Gottlieb has been very public in expressing his desire to provide increased competition and greater choice to American consumers in a bid to drive down prices of prescription medicines. Recently, the agency he oversees took some unusual steps to back up those statements with action. Last week, the FDA approved the use … Continue reading “On Drug Pricing: FDA Backs Up Its Calls for Increased Competition”
Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More
The CEO of a major U.S. pharmaceutical company was in the news this week, but for a change not because of the cost of drugs. Merck CEO Kenneth Frazier (pictured) was the first of what quickly became a line of CEOs to exit President Trump’s manufacturing council, leading to its dissolution altogether. Frazier was widely … Continue reading “Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More”
Expanding Tissue and Squeezing Cells: Meet Xconomy’s Young Innovator Award Finalists
The finalists in the Young Innovator category of the 2017 Xconomy Awards show that it’s never too early in life to start a company or invent a new technology. These four individuals (30 years of age or under) share a strong drive, even a restlessness, to build new things that make a difference. Three knew … Continue reading “Expanding Tissue and Squeezing Cells: Meet Xconomy’s Young Innovator Award Finalists”
Private Equity Investors Have $740 Billion to Spend, Driving Valuations
Private equity investors have more capital at their disposal than at any time in more than a decade, which could boost prices for companies seeking acquisitions. As of Aug. 1, private equity firms in North America and Europe had secured $212.6 billion in new commitments this year, on pace to eclipse the “already stellar” fundraising … Continue reading “Private Equity Investors Have $740 Billion to Spend, Driving Valuations”
PARC Spinout Metawave Adds A.I. to Metamaterials for Autonomous Cars
A serial entrepreneur in the field of metamaterials is building a new company to develop the technology for use in autonomous vehicles and wireless communications. Maha Achour co-founded Metawave early this year, spinning the company out of the storied PARC laboratories, a unit of Xerox, in Palo Alto, CA, with an exclusive license to commercialize … Continue reading “PARC Spinout Metawave Adds A.I. to Metamaterials for Autonomous Cars”
Dragonfly, eGenesis, Spero & More: Xconomy’s Startup Award Finalists
Startups play a critical role in the innovation economy that we chronicle at Xconomy—transforming new ideas that begin in a lab into the products and companies of tomorrow. No surprise, then, that the startup category in our first-ever Awards program was a particularly competitive one, loaded with private companies (no more than 5 years old) … Continue reading “Dragonfly, eGenesis, Spero & More: Xconomy’s Startup Award Finalists”
Seattle Week in Review: Pol Visits, Cash for Donuts, Local M&A
With a shift in the wind, the smoke over Seattle is clearing, only to be replaced by the fear of nuclear war. Tough to stay focused on the tech news, but we’re trying. Here’s a review of visits to the Northwest by two Trump cabinet secretaries; more Amazon real estate news; financing for Donuts and … Continue reading “Seattle Week in Review: Pol Visits, Cash for Donuts, Local M&A”
Kauffman Fellows Take On VC Sexual Harassment, Bench Mentor McClure
If you’re looking for a counterpoint to the recent flurry of news stories about sexual harassment and gender bias in the tech sector, the Kauffman Fellows program isn’t a bad place to start. The Palo Alto, CA-based program, a spinoff of the Ewing Marion Kauffman Foundation, has been a gateway into the venture capital industry … Continue reading “Kauffman Fellows Take On VC Sexual Harassment, Bench Mentor McClure”
Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More
With President Trump holed up in New Jersey, rattling his saber at Kim Jong-un and Mitch McConnell and ignoring his own commission’s advice on the opioid crisis, there was still life sciences news from the nation’s capital. The FDA reported that generic drug approvals are set to hit a record; the agency under Commissioner Scott … Continue reading “Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More”
Tech Hiring Trends: Buzzwords, Trump Effect, and Gender-Pay Gap
As the tech economy continues its historic boom, here’s three views of labor market trends released this week, including the rise and fall of buzzwords in engineering job postings; the Trump Administration’s impact on U.S. companies’ interest in foreign workers; and another disappointing look at the gender-pay gap. —In the last two years, big data … Continue reading “Tech Hiring Trends: Buzzwords, Trump Effect, and Gender-Pay Gap”
Why We All Should Care About the Recent Brouhaha at Google
The issues raised by the 10-page memo on the suitability of women for certain engineering and leadership positions at Google (culminating in the firing of its author) have implications for all of us. They are as much about the requirements for success in today’s workplace—and how to identify and nurture those qualities in all employees—as they … Continue reading “Why We All Should Care About the Recent Brouhaha at Google”
Startup Builders, IPO Closers & More: Meet Xconomy’s CEO Award Finalists
There are many ways to stand out as a biotech CEO, from getting a company started in the first place to pushing its first drug over the finish line. Those differences are what we noticed when going through the nominations from you, the readers, for the top Boston biotech CEO, as part of the first-ever … Continue reading “Startup Builders, IPO Closers & More: Meet Xconomy’s CEO Award Finalists”
The Fired Google Engineer, the First Amendment, and the Alt-Right
Google software engineer James Damore confirmed to Bloomberg on Monday that Google fired him for circulating a lengthy memo on his views that women are biologically less suited to tech work than men. His “manifesto” was spread through Google’s internal communication channels over the weekend, and obtained by Gizmodo and other tech publications. Damore expressed … Continue reading “The Fired Google Engineer, the First Amendment, and the Alt-Right”
Xconomy Awards: The Finalists Are….
The nominees for our first ever Xconomy Awards were an impressive bunch, and represent a wide range of the technologies, approaches, and yes, personalities, that are all driving Boston biotech today. There’s a lot of talent in this town, so narrowing the list of more than 250 nominations down to a handful of finalists in … Continue reading “Xconomy Awards: The Finalists Are….”
Pro.com Becomes a ‘Tech-Enabled General Contractor,’ Raises $10M
Finding someone to repair, remodel, or build your home—the largest asset most people will ever own—is fraught. For years, technology companies such as Angie’s List and HomeAdvisor have been trying to help, with varying degrees of success, by matching homeowners with vetted, reviewed service professionals. Seattle has seen its share of companies pursue a version … Continue reading “Pro.com Becomes a ‘Tech-Enabled General Contractor,’ Raises $10M”
An Insider’s Guide to Bridging the Biotech Gender Gap
As an executive recruiter focused solely on life sciences, I’m among the first to acknowledge the industry’s gender gap. Of the 20 largest pharmaceutical companies around the world, only one has a woman at the helm—and GSK named Emma Natasha Walmsley as CEO less than five months ago. Among biotech executive leadership teams, women make … Continue reading “An Insider’s Guide to Bridging the Biotech Gender Gap”
Opportunity Abounds as Washington Builds the Modern Electricity Grid
[Updated 8/9/17, 9:48 a.m. See below.] In a dry grassland set amid some of the region’s preeminent energy research, production, and training facilities, you can see the future of the electricity grid, and Washington state companies and workers are playing a major role in shaping it. The Horn Rapids Solar, Storage, and Training Project—which would … Continue reading “Opportunity Abounds as Washington Builds the Modern Electricity Grid”
Seattle Week in Review: Blue Angels, Smoke, and Surveillance Above
As the Blue Angels streak across Seattle’s smoke-filled skies preparing for this weekend’s Seafair, we’ll review some of this week’s news, including some of the latest dire climate change forecasts; the race for mayor; Amazon’s ongoing hiring and real estate sprees; odd flight patterns; and a Periodic Table of haiku. —It’s impossible not to think … Continue reading “Seattle Week in Review: Blue Angels, Smoke, and Surveillance Above”
Bio Roundup: CRISPR Advances, Obamacare Lives, FDA Nods & More
Gene editing took an important step this week when a group of U.S. researchers used CRISPR-Cas9 technology to correct a genetic error in dozens of human embryos without complications. It’s a significant achievement, but amidst the hype, it’s worth cautioning just how much work has to be done before the technology leads to a safe … Continue reading “Bio Roundup: CRISPR Advances, Obamacare Lives, FDA Nods & More”
Dramatic Capital Inflows Continue in 2Q17… Trouble Ahead?
In an environment of microscopic interest rates, it is particularly interesting to read the Preqin 2Q17 Quarterly Update, which exhaustively tracks all things private equity and venture capital. At the end of June 2017 there were 1,998 funds in market raising a total of $676 billion – a staggering sum – indicative of global investors … Continue reading “Dramatic Capital Inflows Continue in 2Q17… Trouble Ahead?”
Clinc’s A.I. Lets USAA Members Casually Chat with Their Bank Accounts
Ever wanted to casually talk to your bank account and find out how much money you have in checking, or what your restaurant spending looked like a year ago? If you’re a member of USAA, the financial institution serving members of the U.S. military, and have an Amazon Alexa device, now you can. Clinc, the … Continue reading “Clinc’s A.I. Lets USAA Members Casually Chat with Their Bank Accounts”
Azuqua Gets $10.8M Round for Platform to Integrate Cloud Apps
It should come as no surprise that Cloud City has a proliferation of tech companies helping businesses manage the proliferation of cloud apps. One of these is Azuqua, a four-year-old Seattle startup building software that allows businesses to integrate their various cloud applications to serve specific needs. The company announced a $10.8 million Series B … Continue reading “Azuqua Gets $10.8M Round for Platform to Integrate Cloud Apps”
Booster Fills Up With $20M for On-Demand Gas—Is It ‘Sustainable’?
Add refueling your car to the list of mundane tasks you don’t have to put on your to-do list. Booster Fuels, a service that brings gas to parked cars on-demand, said Tuesday it has raised $20 million to continue growing in the two large markets where it operates: the San Francisco Bay Area and Dallas-Forth … Continue reading “Booster Fills Up With $20M for On-Demand Gas—Is It ‘Sustainable’?”
Disrupt Indy: Can Data Forge the Path to Inclusive Tech Ecosystems?
U.S. tech startups and investment firms have long been thought of as the domain of white men—because historically, they have been. Although that may be changing as more big tech corporations are pressured to release their diversity statistics and change hiring policies, one only needs to look at the statistics to confirm that women, members … Continue reading “Disrupt Indy: Can Data Forge the Path to Inclusive Tech Ecosystems?”
A.I. Chip Race Redraws Competitive Map Among Tech Firms, Chipmakers
It’s been a long time since tech’s biggest companies could be sorted into discrete buckets according to the products they pioneered—-Google, the search software giant; Apple, the computer and mobile device innovator; e-commerce leader Amazon; business software stalwart Microsoft; and social media engine Facebook. Since then, these major innovators have built on a common resource—increasingly … Continue reading “A.I. Chip Race Redraws Competitive Map Among Tech Firms, Chipmakers”
Redfin IPO Raises $138M, Stock to Begin Trading Friday
[Updated, 1:40pm PT. See below] Redfin, a real estate software firm based in Seattle, priced its initial public offering at $15 a share on Thursday, above the projected range of $12 to $14. The IPO raised $138 million, and the company’s stock is set to begin trading on the Nasdaq today under the symbol “RDFN.” … Continue reading “Redfin IPO Raises $138M, Stock to Begin Trading Friday”
Bio Roundup: GOP Drama, Immunotherapy Setbacks, Pharma Revamps
Two failed cancer studies this week provided a fresh reminder how little researchers and clinicians understand about immunotherapy’s vagaries: why it works for some people and not for others. The results, in lung cancer and head-and neck cancer, add to recent failures in multiple myeloma and bladder cancer and splash cold water on a sector … Continue reading “Bio Roundup: GOP Drama, Immunotherapy Setbacks, Pharma Revamps”
Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails
Despite all the great progress made harnessing the immune system to fight cancer, there is still much work to be done to maximize its potential. The latest evidence: disappointing results today from a roughly 1,100-patient study called “Mystic,” a highly anticipated trial from AstraZeneca testing a combination of immunotherapies in newly diagnosed lung cancer patients. … Continue reading “Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails”
Wisconsin Company Offers to Put RFID Chips in Employees’ Bodies
[Updated 7/26/17 10:51 a.m. See below.] Why store information on a thumb drive when you can store it directly in your thumb? Three Square Market, a River Falls, WI-based company that helps clients equip their offices with miniature stores that offer more variety and convenience than vending machines, says it recently offered employees the opportunity … Continue reading “Wisconsin Company Offers to Put RFID Chips in Employees’ Bodies”
Convoy Raises $62M From Gates, Y Combinator for Trucking Marketplace
Convoy, a startup trying to modernize the way truck drivers connect with customers, just got a $62 million boost from investors including the Y Combinator Continuity Fund and Microsoft co-founder Bill Gates. The Seattle startup, which makes technology that would automate the work of freight brokerages and dispatchers, announced the Series B funding round that … Continue reading “Convoy Raises $62M From Gates, Y Combinator for Trucking Marketplace”
$200M Invested For a Global Network of Indoor Farms? That’s Plenty
Agtech startup Plenty has reeled in $200 million in financing as the company presses forward on its plans to build a global network of indoor vertical farms. Softbank Vision Fund of Japan led the Series B funding round for South San Francisco, CA-based Plenty. The round included investments from affiliates of Louis Bacon, the founder … Continue reading “$200M Invested For a Global Network of Indoor Farms? That’s Plenty”
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More
The attempt to repeal and replace the Affordable Care Act took a major hit this week from Senate GOP holdouts who said the Better Care Reconciliation Act either tore down Medicaid too much or left too much of the ACA in place. A straight-up repeal, floated by Senate majority leader Mitch McConnell, was also shot … Continue reading “Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More”
Arzeda Raises $12M for Computational Protein Design
Nine years passed between Arzeda’s emergence from the Baker lab at University of Washington and the $12 million Series A funding round the Seattle computational protein design company announced Thursday. But Arzeda has grown the old-fashioned way: by bringing in revenue from customers, and plowing profits back into the company. The company has developed custom … Continue reading “Arzeda Raises $12M for Computational Protein Design”
New Frontier: Space Center Crowdfunds for Mission Control Facelift
[Updated 7/25/17 5:18 pm. See below.] Houston—Houston, Mission Control has a problem. The storied control room at NASA’s Johnson Space Center in Houston—recognizable to many of us from 1960s news clips of the dawn of the Space Age––is in need of a face-lift. And so, Space Center Houston, the visitor’s center for the JSC, has turned … Continue reading “New Frontier: Space Center Crowdfunds for Mission Control Facelift”
Christopher Ahlberg: The Full Xconomy Voices Interview
The second episode of Xconomy’s new podcast, Xconomy Voices, features Recorded Future co-founder and CEO Christopher Ahlberg. His Somerville, MA-based cybersecurity company monitors both the public, visible Web and the Internet’s darker corners for “threat intelligence” that can help its clients prepare for, and fend off, cyber attacks. Ahlberg’s background in data analytics and his … Continue reading “Christopher Ahlberg: The Full Xconomy Voices Interview”